Roni Brar appointed Stanford Cancer Institute’s Associate Director for Clinical Care.

Rondeep (Roni) Brar

We are delighted to announce that Rondeep (Roni) Brar, MD, clinical associate professor of Medicine, has been appointed Stanford Health Care’s Medical Director for the Cancer Destination Service Line (DSL) and Stanford Cancer Institute’s Associate Director for Clinical Care. He began in these dual roles on Monday, February 6. 

Over the last decade, Dr. Brar has shown tremendous vision in re-imagining and elevating our health system’s inpatient cancer care services and ambulatory hematology practice. This includes engaging with and leading teams to redesign the Advanced Practice Provider (APP) system, improve inpatient documentation, grow patient volumes, and increase and diversify clinical trial enrollments. 

These successes are a testament to Dr. Brar’s strong leadership, expansive expertise, cutting-edge clinical research, and compassionate care. They also reflect his vast institutional knowledge and the strong collegial relationships he has formed across Stanford Medicine.  

Alongside Heather Wakelee, MD, Dr. Brar has served as the Interim Medical Co-Director of the Cancer DSL since August 2021. During this time, Drs. Brar and Wakelee have re-aligned the structure and leadership of the Cancer Care Programs, reconfigured the leadership cabinet to represent a broader constituent group, and engaged in strategic planning for our joint ventures and future campus expansion.

Dr. Brar will work closely with Drs. Artandi and Seshadri as well as Maria Gonzalez, Executive Director of the Cancer DSL, to shape and implement the future of the Cancer DSL. 

Dr. Wakelee will continue to provide interim support through March 2023 as Dr. Brar transitions some of his clinical operations. We want to thank Dr. Wakelee for her dedication and stellar leadership and wish her the best as she continues her exemplary service as the Division Chief of Medical Oncology and her extensive work in clinical trials.  

We also want to express our gratitude to our search committee and the stakeholders across Stanford Medicine who helped facilitate this important search. 

We are excited to have Dr. Brar serve in these leadership roles and look forward to his contributions. Please join us in congratulating Dr. Brar on this well-deserved recognition. 

February 2023